Mirati Therapeutics

-$18.65 (-31.90%) Today
-$0.62 (-1.56%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRTX and other ETFs, options, and stocks.

About MRTX

Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer.

CEO
David D. Meek
Employees
418
Headquarters
San Diego, California
Founded
1995

MRTX Key Statistics

Market cap
2.21B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.85M
High today
$40.51
Low today
$32.96
Open price
$40.33
Volume
12.89M
52 Week high
$195.99
52 Week low
$32.96

MRTX Earnings

-$3.72
-$2.48
-$1.24
-$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure